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ELLIOTT M. Ross PROTEIN MODIFICATION
Palmitoylation in G-protein signaling pathways
The reversible palmitoylation of G proteins and their receptors is
involved both in receptor desensitization and in association and
disassociation of Gex subunits with the plasma membrane.
Some say that geography is destiny. Cell biologists feel
this way, and biochemists are sometimes forced to agree.
Exactly where a signaling protein resides in a cell can
markedly influence what it does, how well it does it and
to whom it does it. In signal transduction pathways, con-
trolled subcellular localization of receptors, G proteins
and effectors influences both the fidelity of signaling -
who talks to whom - and the long-term control of
signaling through receptor endocytosis and down-regula-
tion. Over the past few years, the reversible palmitoy-
lation of both G proteins and G-protein-coupled recep-
tors has been recognized as one way of regulating their
localization and activity.
Both G protein aL subunits and G-protein-coupled recep-
tors are palmitoylated through thioester linkages to
cysteine residues. The receptors, which are intrinsic
membrane proteins based on a bundle of seven hydro-
phobic, membrane-spanning helices, are palmitoylated in
their carboxy-terminal cytoplasmic domains, about 12
residues past the end of the seventh helix. Some receptors
terminate just after this residue, but others contain exten-
sive carboxy-terminal domains of 150 amino-acid residues
or more.
G protein x subunits, which bind GTP and which inter-
act directly with both receptors and effectors, are palmi-
toylated near their amino termini, usually at residue 3.
The most typical mature amino-terminal structure is an
N-myristoylated glycine followed by an S-palmitoylated
cysteine. These hydrophobic modifications of Got sub-
units are in addition to the prenylation, usually by a
geranylgeranyl thioether, of Gy subunits on the carboxy-
terminal cysteine methyl ester.
In the case of the G proteins, which do not have notably
hydrophobic amino-acid sequences and which bind at
the inner surface of the plasma membrane, palmitoylation
and other alkylations increase their overall hydropho-
bicity and promote their attachment to the membrane.
For the already hydrophobic receptors, the differential
hydrophobicity contributed by a palmitoyl group is triv-
ial. In either case, why has biology chosen alkylation as a
way of increasing hydrophobicity rather than the perma-
nent addition of a few more leucine or valine residues?
There are at least two answers.
First, palmitoylation may enhance binding to particular
proteins rather than just enhancing membrane attach-
ment. Such recognition of specific cellular structures can
change the location of receptors or G proteins in cells.
The reversibility of the palmitoylation, triggered directly
or indirectly by an agonist, raises the even more enticing
prospect that the cell can regulate both the relocaliza-
tion of signaling proteins and their associations with
other proteins.
Regulated turnover of receptor palmitoylation
Ever since the palmitoylation of rhodopsin was first
observed in 1988 [1], a small but steady series of papers
has described palmitoylation of other G-protein-coupled
receptors; nearly all the receptors contain the palmitoy-
latable cysteine residue after the seventh span. But muta-
tion of this cysteine- generally has subtle, if any, effects.
An engineered rhodopsin mutant with no cytoplasmic
cysteine residues is functionally wild type when measured
in an in vitro reconstituted assay [2]. Similarly, cysteine
missense mutants of 132-adrenergic [3], D 1 dopaminergic
[4] and eo2A-adrenergic [5] receptors, which do not
become palmitoylated, have all been reported to display
unaltered signaling phenotypes when expressed (at fairly
high levels) in cultured cells. In another study, a similar
cysteine mutation in the 132-adrenergic receptor caused
only subtle changes in G-protein coupling [6,7].
Two observations by Bouvier and co-workers [3,4] made
receptor palmitoylation more intriguing by linking it to
receptor desensitization, which occurs upon the contin-
ued exposure of cells to agonists. Desensitization and
subsequent resensitization of G-protein-coupled recep-
tors are the result of a complex set of processes. They
include receptor phosphorylation by at least two protein
kinases, decreased coupling to G protein (probably
caused both by phosphorylation and by the binding of
inhibitory proteins known as arrestins), receptor endo-
cytosis and degradation, and (frequently) a decrease in
new receptor synthesis.
How does palmitoylation fit in with these processes?
Mouillac et al. [3] reported that continued exposure of
cells to agonist increases the slow, in vivo labeling of
32-adrenergic receptors with [3H]palmitic acid, an obser-
vation later confirmed for D 1 receptors [4]. Of even
greater interest, a non-palmitoylated mutant receptor
(Cys341Gly) displayed several features of desensitization
without exposure to agonist. The mutant receptor was
active in signaling, but a little less so than the wild type.
Unlike the wild-type receptor, however, the mutant was
not much uncoupled by continued agonist exposure. The
mutant receptor was also more highly phosphorylated
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than the wild type in the absence of agonist, but was not
phosphorylated much further when agonist was added.
Similar observations were made for an analogous mutant
D 1 receptor [4].
When these phenomena are put together and some tech-
nical inadequacies overlooked, they make a story that
links turnover of palmitoyl groups to receptor desen-
sitization. The simplest version of the story is that un-
stimulated receptor in the plasma membrane is largely
palmitoylated. When stimulated by agonist, the receptor
not only activates G protein, but also becomes a better
substrate for the enzyme palmitoyl-protein thioesterase,
which removes palmitoyl groups [8]. Depalmitoylation
triggers receptor phosphorylation, consequent uncoup-
ling and (perhaps) later endocytosis. In this scheme, the
observed stimulation of labeling with [3 H]palmitate in
response to continued exposure to agonist reflects some
part of the resensitization pathway, perhaps that involved.
in movement of receptors into or out of endosomes [9].
More detailed speculations can be left to the imagination
of the reader.
Now for the hard part. So far, it has not been possible
to measure receptor palmitoylation. Labeling with
[3H]palmitate is expensive, inefficient and hard to detect
- two-week exposure of fluorographs of gels of
immunoprecipitates or affinity-purified receptor is the
norm. Further, labeling with [3H]palmitate may reflect
increased steady-state palmitoylation, unchanged net
palmitoylation combined with rapid turnover, or even a
net decrease in palmitoylation if thioesterase activity is
high. So far, there are no data that speak (even qualita-
tively) to the loss of palmitate from prelabeled receptor.
Second, it is unclear which population of receptor -
palmitoylated or unpalmitoylated - is under observation
in assays of signaling, phosphorylation or endocytosis.
Last, some receptors lack the palmitoylated cysteine yet
undergo the cycle of uncoupling, endocytosis and recov-
ery. Thus, although receptor palmitoylation certainly
seems to be involved in modulating sensitivity to agon-
ists, and in very interesting ways, its control and mecha-
nism of action remain open questions for the G-protein
signaling community.
Ga subunit palmitoylation and depalmitoylation
Like the receptors that regulate them, G protein 
subunits also undergo a cycle of depalmitoylation and
palmitoylation. G subunits are palmitoylated on a
conserved cysteine residue, usually found at position 3
[10,11], and palmitoylation enhances Got binding to
membranes. A non-palmitoylated mutant of Goot is
found primarily in the cytosol, and the analogous Cys3
mutants of Gsot and Gqa, the wild-type forms of which
bind more tightly to membranes than does Got, are
found in cytosol fractions at least to some extent [12,13].
This diminished membrane binding may in fact com-
pletely account for the diminished signaling activities
noted in some of these mutants [13], because non-palmi-
toylated Ga subunits are active in vitro. G, Goa and
Gqao are all largely depalmitoylated during purification, as
assessed by their abilities to form disulfides either with
mastoparans (short receptor-mimetic peptides [14]) or
with another cysteine residue near the carboxyl terminus
(T. Higashijima and myself, unpublished data). All, how-
ever, remain responsive to receptors and purified Gsoa
and Gqoa efficiently activate their respective effector
proteins, adenylyl cyclase and phospholipase C-P.
Like receptors, Ga subunits undergo accelerated
depalmitoylation and repalmitoylation when they are
activated within the cell during signal transduction. The
effects of activation on palmitate turnover on Gat are
similar whether activation is by receptors, or is the result
of covalent modification by cholera toxin (for Gs) or of a
mutation that increases the rate of activation by cellular
GTP [12,15,16]. In the most thorough study to date,
Wedegaertner and Bourne [16] have clarified the linkage
between the activation and palmitoylation cycles, and
have indirectly estimated the stoichiometry of palmitate
turnover. First, they found that activation increased the
rate of depalmitoylation of Gsot that had been prelabeled
with [3H]palmitate. Activation promoted complete
removal of [3 H]palmitoyl groups. They argue convin-
cingly that the kinetics of labeling and the subcellular
localization of G a are consistent with activation-induced
depalmitoylation of membrane-bound Gsa. Depalmi-
toylation allowed the Got to leave the plasma membrane,
and repalmitoylation occurred in the cytoplasm. Because
both they and Degtyarev et al. [15] had found that a
mutation that inhibits dissociation of Gao from GJy also
inhibits the palmitate cycle, Wedegaertner and Bourne
inferred that dissociation of activated Ga from Gy
precedes hydrolysis of the palmitoyl group and that
depalmitoylation is the decisive event in releasing Ga
from the membrane. This idea is supported by the obser-
vation that depalmitoylation of detergent-solubilized Gsoa
was inhibited by GJ3y.
The conclusion of this work, assuming that it is con-
firmed, is that activation-promoted depalmitoylation of
Goa subunits causes their slow transfer to the cytosol.
Does this mean that the Got subunits activate cytosolic
targets while there? Probably not. Although G proteins
deactivate slowly, all but the slowest hydrolyze their
bound GTP in less than 3 minutes at 37 OC; Gs and Gi
are much faster than this. Thus, by the time much
depalmitoylated Ga gets to the cytosol, it is in the inac-
tive, GDP-bound state. The predominant cytosolic
species would thus be inactive. Depalmitoylation is more
probably involved in long-term regulation of the signal-
ing activity of Ga subunits, perhaps by altering their
associations with other important proteins. Results with
the Cys 3 mutants are consistent with this idea.
True solubilization of Ga subunits by removal of a
palmitoyl anchor may also be an oversimplification. As
argued by Resh [17], the hydrophobicity of a palmitoyl
group is insufficient to anchor a protein to a bilayer. The
observed release might indicate that palmitoylation is
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important for binding to another membrane protein,
Gpy perhaps. Alternatively, the observed release may
only reflect the massive dilution of cytosol that occurs
when cells are homogenized. In cells, depalmitoylated
Ga may never leave the membrane but only redistribute
laterally. The questions that remain are where the
depalmitoylated Ga goes, what it does when it gets there
and how it gets palmitoylated again and returned to the
signaling switchboard.
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